Who is sponsoring NCT06320665?

NCT06320665 is sponsored by Central Hospital, Nancy, France.

What drugs are being tested in NCT06320665?

Interventions in NCT06320665: Radiographic measurement.

What condition does NCT06320665 study?

NCT06320665 studies Impacted Third Molar Tooth.

Is NCT06320665 still recruiting?

NCT06320665 is currently recruiting now. Last updated 28 March 2025.

Last reviewed 2025-03-28 · How we verify

NCT06320665

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of Vertical Pattern in Correlation With Third Molar Inclusion : A 3D CBCT Analysis

Recruiting now Last updated 28 March 2025

What this trial tests

trial testing Radiographic measurement in Impacted Third Molar Tooth in 80 participants. Currently enrolling.

Timeline

1 December 2024

Primary endpoint
30 July 2025

30 September 2025

Quick facts

Lead sponsor	Central Hospital, Nancy, France
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	80
Start date	1 December 2024
Primary completion	30 July 2025
Estimated completion	30 September 2025
Sites	1 location across France

Drugs / interventions tested

Radiographic measurement

Conditions studied

Impacted Third Molar Tooth — all drugs for Impacted Third Molar Tooth →

Sponsor

Central Hospital, Nancy, France

Who can join

15 and older, any sex, with Impacted Third Molar Tooth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective is to compare the sagittal and vertical skeletal parameters of patients with an impacted third molar. Patients will be analyzed according to their skeletal characteristics: skeletal class (sagittal direction) and facial skeletal typology (vertical direction). The inclusion characteristics of third molars will also be analyzed, to see the links between typology and inclusion. The principal hypothesis is no significant difference in third molar inclusion patterns in relation to skeletal divergence.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Impacted Third Molar Tooth

Currently open trials in the same condition.

NCT06514222 — Pain Control Following Third Molar Surgery · EARLY_PHASE1 · active not recruiting

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06320665 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
Last refreshed: 28 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06320665.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing